Brokerages predict that DocuSign, Inc. (NASDAQ:DOCU – Get Rating) will report sales of $581.06 million for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for DocuSign’s earnings. The lowest sales estimate is $580.61 million and the highest is $582.00 million. DocuSign posted sales of $469.08 million in the same quarter last year, which suggests a positive year over year growth rate of 23.9%. The company is expected to issue its next quarterly earnings results after the market closes on Monday, January 1st.
According to Zacks, analysts expect that DocuSign will report full year sales of $2.48 billion for the current fiscal year, with estimates ranging from $2.47 billion to $2.48 billion. For the next financial year, analysts anticipate that the business will post sales of $2.95 billion, with estimates ranging from $2.82 billion to $3.03 billion. Zacks’ sales averages are a mean average based on a survey of research analysts that follow DocuSign.
DocuSign (NASDAQ:DOCU – Get Rating) last announced its quarterly earnings data on Thursday, March 10th. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.10). DocuSign had a negative net margin of 3.32% and a negative return on equity of 12.39%. The firm had revenue of $580.83 million for the quarter, compared to the consensus estimate of $561.60 million. During the same period last year, the company posted ($0.08) earnings per share. DocuSign’s revenue for the quarter was up 34.8% on a year-over-year basis.
DocuSign stock opened at $83.78 on Friday. DocuSign has a one year low of $64.84 and a one year high of $314.76. The business has a fifty day moving average price of $88.48 and a 200-day moving average price of $122.04. The company has a debt-to-equity ratio of 2.61, a current ratio of 0.96 and a quick ratio of 0.96. The firm has a market capitalization of $16.75 billion, a P/E ratio of -239.37 and a beta of 1.05.
In other news, COO Scott V. Olrich sold 3,948 shares of the firm’s stock in a transaction dated Tuesday, April 5th. The shares were sold at an average price of $110.09, for a total value of $434,635.32. Following the completion of the sale, the chief operating officer now directly owns 230,663 shares of the company’s stock, valued at approximately $25,393,689.67. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Daniel D. Springer bought 66,882 shares of the company’s stock in a transaction dated Tuesday, March 15th. The stock was bought at an average cost of $74.76 per share, with a total value of $5,000,098.32. The disclosure for this purchase can be found here. Corporate insiders own 2.55% of the company’s stock.
Several large investors have recently bought and sold shares of DOCU. Wagner Wealth Management LLC purchased a new position in DocuSign during the 3rd quarter valued at about $27,000. Nelson Van Denburg & Campbell Wealth Management Group LLC increased its stake in DocuSign by 440.0% during the 1st quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 270 shares of the company’s stock valued at $28,000 after purchasing an additional 220 shares in the last quarter. Retirement Planning Co of New England Inc. bought a new stake in DocuSign during the 4th quarter valued at about $30,000. HM Payson & Co. increased its stake in DocuSign by 102.8% during the 4th quarter. HM Payson & Co. now owns 217 shares of the company’s stock valued at $33,000 after purchasing an additional 110 shares in the last quarter. Finally, Versant Capital Management Inc increased its stake in DocuSign by 21,900.0% during the 4th quarter. Versant Capital Management Inc now owns 220 shares of the company’s stock valued at $34,000 after purchasing an additional 219 shares in the last quarter. 75.62% of the stock is owned by hedge funds and other institutional investors.
About DocuSign (Get Rating)
DocuSign, Inc provides electronic signature software in the United States and internationally. The company provides e-signature solution that enables businesses to digitally prepare, sign, act on, and manage agreements. It also offers CLM, which automates workflows across the entire agreement process; Insights that use artificial intelligence (AI) to search and analyze agreements by legal concepts and clauses; Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce; Negotiate for Salesforce that supports for approvals, document comparisons, and version control; Analyzer, which helps customers understand what they're signing before they sign it; and CLM+ that provide AI-driven contract lifecycle management.
- Get a free copy of the StockNews.com research report on DocuSign (DOCU)
- MarketBeat: Week in Review 5/30 – 6/3
- Dividend Capture Strategy: What You Need to Know
- Okta On Verge Of Multi-Week Rally
- Don’t Bet On A Bounce For RH
- Xiaomi Co: Facing Macro Headwinds
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.